Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
for Metastatic Castrate Resistant Prostate Cancer
Drug: Olaparib
18 locations incl. West Los Angeles
Sponsor: VA Office of Research and Development
Sex: Male·Age: 18+
Code: NCT04038502·Phase 2·Recruiting